iTeos Therapeutics
ITOS
ITOS was delisted on the 28th of August, 2025.
1 hedge funds and large institutions have $2.35K invested in iTeos Therapeutics in 2025 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 135 closing their positions.
98.8% less ownership
Funds ownership: 98.8% → 0% (-99%)
99% less funds holding
Funds holding: 136 → 1 (-135)
100% less funds holding in top 10
Funds holding in top 10: 4 → 0 (-4)
100% less capital invested
Capital invested by funds: $377M → $2.35K (-$377M)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 135
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
IA
IFP Advisors
Tampa,
Florida
|
+$20 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EC
EcoR1 Capital
San Francisco,
California
|
-$107M |
| 2 |
BlackRock
New York
|
-$45.6M |
| 3 |
TCM
Tang Capital Management
San Diego,
California
|
-$38.2M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$16.6M |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
-$8.3M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
HCA
126
Harbor Capital Advisors
Chicago,
Illinois
| – | -$1K | -148 | Closed |
|
127
Raymond James Financial
St Petersburg,
Florida
| – | -$1.25K | -125 | Closed |
|
|
TWD
128
True Wealth Design
Akron,
Ohio
| – | -$1.25K | -125 | Closed |
|
129
Daiwa Securities Group
Tokyo,
Japan
| – | -$1K | -121 | Closed |
|
|
FFA
130
Farther Finance Advisors
San Francisco,
California
| – | -$1.2K | -120 | Closed |
|
|
HFS
131
Hantz Financial Services
Southfield,
Michigan
| – | -$1K | -100 | Closed |
|
|
GI
132
GAMMA Investing
Foster City,
California
| – | -$758 | -76 | Closed |
|
133
Osaic Holdings
Scottsdale,
Arizona
| – | -$558 | -56 | Closed |
|
|
AF
134
Allworth Financial
Folsom,
California
| – | -$399 | -40 | Closed |
|
|
CA
135
Clearstead Advisors
Cleveland,
Ohio
| – | -$130 | -13 | Closed |
|
ITOS Hedge Fund Activity: Q3 2025 in Review
1 of the 7,620 institutional investors tracked by Wall St. Rank reported a position in iTeos Therapeutics (ITOS) for Q3 2025, worth a combined $2.35K — down 100% from $377M a quarter earlier.
Sellers outnumbered buyers: 135 funds closed out of ITOS and 0 opened new positions — a net loss of 135 holders — while 0 trimmed existing stakes and 1 added.
The largest buyer was IFP Advisors, adding an estimated $20. The largest seller was EcoR1 Capital, exiting entirely with an estimated $107M sold.
- 1 institutional investor held iTeos Therapeutics (ITOS) as of Q3 2025, down from 136 in Q2 2025.
- Funds reported $2.35K of iTeos Therapeutics stock for Q3 2025, down 100% quarter-over-quarter.
- 0 funds opened new iTeos Therapeutics positions in Q3 2025 and 135 closed out, a net change of -135 holders.
- The largest iTeos Therapeutics buyer in Q3 2025 was IFP Advisors, an estimated $20 added.
- The largest iTeos Therapeutics seller in Q3 2025 was EcoR1 Capital, an estimated $107M sold.
Based on aggregated 13F filings for Q3 2025.